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2ϩ -dependent contraction; Ca 2ϩ sensitization; gastrointestinal smooth muscle SMOOTH MUSCLE DEVELOPMENT normally proceeds in a wellorchestrated manner before and after birth (32) . Rapid growth and maturation of smooth muscle-containing organ systems are hallmarks of fetal development. Internal organs are formed in the mid-to late stages of embryogenesis with differentiationspecific smooth muscle protein markers seen first in the vascular outflow tract, followed by the bronchial buds, gut, peripheral vasculature, and bladder (27) . Subsequent smooth muscle maturation during fetal and postnatal development correlates with the need for increasing contractile capacity brought about by growing demands for organ function. Thus, the pattern and timing of smooth muscle development vary with the organ or vascular bed studied. In support of this, functional maturation of the ovine bladder and umbilical artery smooth muscle occurs early in development (3, 5) . In contrast, uterine smooth muscle is not essential until sexual maturation; therefore, maturation is delayed long after birth (4) . In the gastrointestinal tract, smooth muscle cells appear as soon as at 5 wk of gestation, and smooth muscle layers become thicker with increasing gestation, which continues well beyond after birth (15) . Information about the development of contractility in gastrointestinal smooth muscle is lacking.
Smooth muscle contraction in response to agonists is related to the increase in cytoplasmatic Ca 2ϩ concentration ([Ca 2ϩ ] i ) as consequence of activation of Ca 2ϩ influx or Ca 2ϩ release from intracellular stores, which initiates smooth muscle contraction upon binding to calmodulin. The Ca 2ϩ -calmodulin complex induces calmodulin-dependent activation of myosin light chain (MLC) kinase (MLCK), which catalyzes the phosphorylation of the myosin regulatory light chain, cross-bridge cycling, and force development (17) . Dephosphorylation of the myosin regulatory light chain is performed by MLC phosphatase (MLCP), leading to relaxation (16) .
It is now well established that smooth muscle can also contract independently of changes in [Ca 2ϩ ] i . This process, referred as Ca 2ϩ sensitization, is the result of changes in the sensitivity of the contractile machinery to Ca 2ϩ . Inhibition of MLCP, decreased MLC desphosphorylation, and subsequent force development mediate Ca 2ϩ sensitization (38) . One main pathway for the inhibition of MLCP involves Rho-kinase (ROCK), the downstream intermediary of the small G protein RhoA, which inhibits MLCP through 130-kDa subunit myosin phosphatase targeting 1 (MYPT1). Ca 2ϩ sensitization can also be activated by the PKC/C-kinase-dependent phosphatase inhibitor of 17 kDa (CPI-17) pathway, where activated PKC phosphorylates CPI-17, which inhibits MLCP by mean of its catalytic subunit PP1␤ (12, 19, 20) .
Relatively little is known for any smooth muscle about the source of Ca 2ϩ for contraction in neonatal animals, and what is known does not present a consistent pattern. Thus, in comparing the contribution of the sarcoplasmic reticulum (SR) or external Ca 2ϩ entry to agonist-evoked contractions in neonatal and adult tissues, relatively more dependence on the SR was found in some studies (14, 31, 33) , but in others, neonatal smooth muscle relies more on extracellular Ca 2ϩ and L-type Ca 2ϩ channels for contraction than does the adult tissue (6, 14, 41) . Regarding Ca 2ϩ -independent contraction, there are also controversial results, and both upregulation (1, 31, 37) and downregulation (9, 10) of Ca 2ϩ sensitization mechanisms have been reported. In this study, we report that in neonatal gastrointestinal smooth muscle, Ca 2ϩ release from intracellular stores is of greater magnitude than in adult smooth muscle, but the associated contraction is smaller, indicating altogether that both Ca 2ϩ -dependent and -independent contractility are developmentally regulated.
MATERIALS AND METHODS
Tissue preparation. Gallbladders were removed from 10-day-old and 4-mo-old male guinea pigs after deep halothane anaesthesia and cervical dislocation and were immediately placed in cold KrebsHenseleit solution (for composition, see Solutions and drugs) at pH 7.35. The gallbladder was opened from the end of the cystic duct to the base and trimmed of any adherent liver tissue. Afterward, the preparation was washed with Krebs-Henseleit solution to remove residual bile. Twenty newborn and twenty-five adult animals were used in the study. All procedures were reviewed and approved by the office of Animal Care Management at the University of Extremadura.
Contraction recording of gallbladder smooth muscle strips. The gallbladder was cut in longitudinal full-thickness strips (3 ϫ 8 mm) that were placed vertically in a 10-ml organ bath filled with KrebsHenseleit solution maintained at 37°C and gassed with 95% O 2-5% CO2. Isometric contractions were measured using force displacement transducers that were interfaced with a Macintosh computer using a MacLab hardware unit and software (AD Instruments, Colorado Springs, CO). Muscle strips were placed under an initial resting tension equivalent to a 1-and 1.5-g load for newborn and adult strips, respectively. Every strip coming from the same animal was used in a different experimental protocol. Cumulative concentration-response curves to CCK were built in the absence or presence of inhibitors for ROCK-and PKC-dependent pathways. Inhibitors were added to the organ bath 30 min before the second curve started.
Cell isolation. After the removal of the mucosa, the gallbladder muscularis propria was cut into small pieces and incubated for 35 min at 37°C in enzyme solution (for composition, see Solutions and drugs) supplemented with 1 mg/ml BSA, 1 mg/ml papain, and 1 mg/ml dithioerythritol. The tissue was then transferred to fresh enzyme solution containing 1 mg/ml BSA, 1 mg/ml collagenase, and 100 M CaCl 2 and incubated for 10 min at 37°C. After a wash with cold enzyme solution, single smooth muscle cells were mechanically isolated using a fire-polished glass Pasteur pipette. Cell suspensions were kept in enzyme solution at 4°C until use, generally within 6 h. Cell viability (ϳ90%), as assessed by trypan blue staining, was the same in all groups of animals.
Cell loading and [Ca 2ϩ ]i determination. [Ca 2ϩ ]i was determined by epifluorescence microscopy using the fluorescent ratiometric Ca 2ϩ indicator fura-2. Isolated cells were loaded with 4 M fura-2 AM at room temperature for 25 min. An aliquot of cell suspension was placed in an experimental chamber made with a glass poly-D-lysinetreated coverslip (0.17 mm thick) filled with Na ϩ -HEPES solution (for composition, see Solutions and drugs) and mounted on the stage of an inverted microscope (Eclipse TE2000-S, Nikon). After cell sedimentation, a gravity-fed system was used to perfuse the chamber with Na ϩ -HEPES solution in the absence or presence of experimental agents. Cells were illuminated at 340 and 380 nm by a computercontrolled monochromator (Optoscan, Cairn Research) at 0.3-1 cycles/s, and the emitted fluorescence was selected by a 510/40-nm bandpass filter. The emitted fluorescence images were captured with a cooled digital charge-coupled device camera (ORCAII-ER, Hamamatsu Photonics) and recorded using dedicated software (Metafluor, Universal Imaging). . Mouse anti-␣-tubulin monoclonal antibody (1:1,000, Santa Cruz Biotechnology) was used to control for protein loading. After a wash, membranes were incubated for 1 h at room temperature with anti-mouse (1: 10,000, Amersham Biosciences, Bucks, UK) or anti-rabbit (1:7,000, Santa Cruz Biotechnology) horseradish peroxidase-conjugated IgG secondary antibodies. Bands were visualized using the supersignal west pico chemiluminescent substrate (Pierce, Rockford, IL), quantified using Gel-Pro analyzer software (version 4.0), and normalized to ␣-tubulin content. In protein phosphorylation assays, two similar gels were run, and one membrane was incubated with the antibody against the total protein and the other with an anti-phospho-protein of interest.
Solutions and drugs. The Krebs-Henseleit solution contained (in mM) 113 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 KH2PO4, 1.2 MgSO4, 25 NaHCO3, and 11.5 D-glucose. This solution had a final pH of 7.35 after equilibration with 95% O2-5% CO2. The enzyme solution used to disperse cells was made up of (in mM) 10 HEPES, 55 NaCl, 5.6 KCl, 80 sodium glutamate, 2 MgCl2, and 10 D-glucose, with pH adjusted to 7.3 with NaOH. The Na ϩ -HEPES solution contained (in mM) 10 HEPES, 140 NaCl, 4.7 KCl, 2 CaCl2, 2 MgCl2, and 10 D-glucose, with pH adjusted to 7.3 with NaOH. The Ca 2ϩ -free Na ϩ -HEPES solution was prepared by substituting EGTA (1 mM) for CaCl2. The lysis solution contained 50 mM Tris ⅐ HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.5% (wt/vol) NaN3, 1 mM EGTA, and 0.4 mM EDTA supplemented with a cocktail of protease and phosphatase inhibitors (Complete, EDTA-free and PhosSTOP, Roche Molecular Biochemicals, Mannheim, Germany).
Drug concentrations are expressed as final bath concentrations of active species. Drugs and chemicals were obtained from the following sources: bethanechol, caffeine, CCK (26 -33) (CCK-8) sulfated, DTT, ionomycin, and thapsigargin (TPS) from Sigma Chemical (St. Louis, MO); fura-2 AM from Molecular Probes (Molecular Probes Europe, Leiden, The Netherlands); collagenase from Fluka (Madrid, Spain); papain from Worthington Biochemical (Lakewood, NJ); and Y-27632 and GF109203X from Calbiochem (La Jolla, CA). The Na ϩ -Ca 2ϩ exchanger (NCX) inhibitor SEA-0400 (26) was provided by Taisho Pharmaceutical. Other chemicals used were of analytical grade from Panreac (Barcelona, Spain). Stock solutions of fura-2 AM and TPS were prepared in DMSO. The solutions were diluted such that the final concentration of DMSO was Յ0.1% (vol/vol). This concentration of DMSO did not have any effect on gallbladder tone. Quantification and statistics. Results are expressed as means Ϯ SE of n cells or gallbladder strips. All results from [Ca 2ϩ ]i determinations are given as ⌬F340/F380. Gallbladder tension is given in millinewtons per milligram of tissue. Statistical differences between means were determined by Student's t-test. Statistical differences between multiple groups or the effects of inhibitor treatments were tested using the appropriate ANOVA. To estimate the speed of recovery of Ca 2ϩ signals, the half-time (t1/2) of the decay was estimated for each individual cell using interpolation. Differences were considered significant at P Ͻ 0.05.
RESULTS

Contractile response and Ca
2ϩ mobilization to CCK in the newborn. The neonatal gallbladder contracts in a concentration-dependent manner in response to CCK, as shown in Fig. 1A . However, the contractility was significantly lower in neonatal smooth muscle than in adult smooth muscle (Fig. 1A) (36) . In adult cells, the blockade of both PMCA by 1 mM La 3ϩ and NCX by 1 M SEA-0400 before CCK challenge resulted in a decrease in the speed of Ca 2ϩ decay ( Fig. 2A) , as indicated by the increase in the t 1/2 of the decay (Fig. 2C) . However, in newborn cells, the blockers did not change the speed of the decay (Fig. 2B) It could also be possible that an increase in the activity of the SERCA pump was responsible for the increase in the Ca 2ϩ store content. To test this, we assayed CCK in the presence of the SERCA blocker TPS (1 M) in cells from both ages. As shown in Fig. 3 , in either adult and newborn cells, TPS significantly delayed the Ca 2ϩ decay, but the increase in t 1/2 was higher in the newborn, which suggests that the activity of SERCA pump is enhanced in newborn cells. La 3ϩ ϩ SEA-0400 caused an extra delay in TPS-treated adult cells (189% of the increase), whereas in TPS-treated newborn cells, there was not any extra increase (TPS: 14.99 Ϯ 2.11 s and TPS ϩ La 3ϩ ϩ SEA-0400: 17.51 Ϯ 3.15 s, n ϭ 15 and 12 cells, respectively). A higher expression in SERCA in neonatal cells can be ruled out since when we quantified the expression of this protein, no significant differences between both age groups were found (Fig. 4A) . In smooth muscle cells, among other cell types, SERCA activity is controlled by the phosphorylation level of PLB. Thus, in the unphosphorylated state, PLB inhibits or slows SERCA activity, but PLB phosphorylation relieves SERCA, which increases the rate of Ca 2ϩ pumping (23) . The expression of PLB was decreased in newborn cells (Fig. 4B) , which could explain the higher activity of the SERCA pump. In addition, in response to CCK challenge, the level of PLB phosphorylation (expressed with respect to total PLB) was higher in newborn cells (Fig. 4C) , which would end in an increase in the activity of SERCA.
It could be possible that the lower Ca 2ϩ transient in newborn smooth muscle in response to high K ϩ described above was due to greater SERCA activity in the newborn. To test this hypothesis, we investigated the effects of TPS on high K ϩ -induced Ca 2ϩ transients and contractility. In both newborn and Ca 2ϩ sensitization mechanisms in the newborn. To investigate whether Ca 2ϩ sensitization mechanisms are developmentally regulated, specific inhibitors of Ca 2ϩ sensitization pathways were tested on the contractile response of the guinea pig gallbladder. In these experiments, strips were challenged twice with CCK at a 60-min interval. Inhibitors were added to the organ bath 30 min before the second challenge. Y-27632 (5 M), a specific inhibitor of ROCK (40) , and the selective PKC antagonist GF-109203X (5 M) (39) were used to evaluate the contribution of RhoA/ROCK and PKC/CPI-17 pathways, respectively. In adult animals, the contractile response evoked by CCK was significantly reduced by either Y-27632 or GF-109203X (Fig. 5, A and C) . However, in neonatal strips, the inhibitors did not have any significant effect (Fig. 5, B and D) . These results suggest that Ca 2ϩ sensitization mechanisms are not collaborating in agonist-induced gallbladder contractility in the newborn.
To test this further, we determined the expression of proteins involved in Ca 2ϩ sensitization pathways. As shown in Fig. 6A , development increased the expression of the main components of the RhoA/ROCK pathway. In addition, phosphorylation of the effector MYPT1 (at Thr 853 ) in response to CCK challenge was decreased in newborn tissue (Fig. 6B) . Similarly, expression of p-PKC was reduced in the neonatal gallbladder, and, although the expression of its effector CPI-17 was the same in both groups (Fig. 7A) , CPI-17 phosphorylation (at Thr 38 ) in response to CCK was diminished in the newborn gallbladder (Fig. 7B) .
DISCUSSION
The present study demonstrates that gallbladder contraction is weak in the newborn. The decreased contractility is associated with decreased Ca 2ϩ influx and enhanced Ca 2ϩ release from stores, with the latter as a consequence of overactivity of the SERCA pump and reduced efficiency of plasmalemma Ca 2ϩ extrusion mechanisms. Despite the increased Ca 2ϩ profiles in response to CCK, the neonatal gallbladder smooth muscle contracts less than adult tissue in response to CCK. This is probably related to the immaturity of Ca 2ϩ sensitization mechanisms that collaborate in agonist-induced contraction in the adult.
To antibodies on adult and newborn gallbladder smooth muscle. Bands around 75 and 20 kDa were obtained for SERCA2 and PLB, respectively. Actin content was used as loading control. Note that SERCA expression was similar in both age groups, but PLB expression was decreased in the newborn. C: CCK-induced PLB phosphorylation was estimated by the relative expression of phosphorylated (p-)Ser 16 -PLB in control and CCK-treated smooth muscle. In the newborn, PLB was phosphorylated to a higher extent than in adult tissue, which would relieve the SERCA pump in this age group. Histograms show summary data (means Ϯ SE) of 6 -8 experiments. *P Ͻ 0.05.
gallbladder smooth muscle at birth, Ca 2ϩ influx through them is lower than in adult cells. This may suggest a decrease in the expression of these channels or changes in their conductance/ electrical properties. The lower Ca 2ϩ transient in newborn smooth muscle in response to high K ϩ could be due to the greater SERCA activity in newborn smooth muscle. However, in TPS-treated cells, high K ϩ -induced Ca 2ϩ influx is lower in both age groups, indicating that in this tissue, CICR participates in K ϩ -induced Ca 2ϩ mobilization, which makes it difficult to assess if SERCA overactivity is in part responsible for the reduction in Ca 2ϩ entry in the newborn. To date, there has been no study that addresses the intimate causes for delayed development or functional immaturity of Ca 2ϩ signaling in neonatal gallbladder smooth muscle, which needs to be explored. In several tissues, Ca 2ϩ influx has been shown to vary with developmental age. In cerebral arteries, KCl-dependent contraction was also reduced, but the L-type Ca 2ϩ channel contribution to agonist-induced contraction and Ca 2ϩ mobilization in fetal and newborn smooth muscle cells was higher than in the adult (24, 43) . Similarly, the neonatal myocardium is much more dependent on transmembrane Ca 2ϩ influx and less dependent on Ca 2ϩ release from intracellular storage sites than the adult myocardium (8, 21) . However, in the neonatal uterus, it has been shown that both extracellular Ca 2ϩ entry and SR Ca 2ϩ release contribute to the response to agonists, although the reliance in Ca 2ϩ entry is less in neonatal tissues The histogram (right) shows summarized data of changes in protein expression in both experimental groups. For each protein, the band optic density is expressed in respect to that of actin to correct the amount of protein loaded. In the newborn, there was reduced expression of ROCK I, ROCK II, and the effector myosin phosphatase targetting 1 (MYPT1). B, left: representative Western blots using anti-p-Thr 853 -MYPT1 and anti-MYPT1 in unstimulated [control (C)] or CCK-treated adult and newborn samples. The histogram (right) shows summarized data of changes in protein expression and MYPT1 phosphorylation in 5 experiments. After referenced to actin content, the optic density of p-MYPT1 (top) versus total MYPT1 (bottom) was calculated for control and CCK-treated samples in both age groups, and the ratio for CCK-treated samples was expressed as the fold increase with respect to unstimulated conditions. Note that CCKinduced MYPT-1 phosphorylation was decreased in the newborn. Actin was used as a loading control. *P Ͻ 0.05 and **P Ͻ 0.01 by ANOVA. compared with adult tissues (30) . Ca 2ϩ influx through capacitative Ca 2ϩ channels is also reduced in the newborn, which is not surprising, taking into account that we (28) release from the SR is more prominent in the newborn gallbladder than in the adult gallbladder. We (29) have previously found that the SR in gallbladder smooth muscle comprises a Ca 2ϩ store that is shared by both the inositol 1,4,5-trisphosphate receptor and ryanodine receptor, which can be stimulated by CCK and caffeine, respectively. In the present study, Ca 2ϩ transients evoked by both CCK and caffeine are higher in neonatal tissues than in adult tissues, which correlates with the greater amount of Ca 2ϩ stored in the SR in the younger age group. We postulate from our data that the size of the Ca 2ϩ release is higher in the newborn compared with the adult as a consequence of development or functional immaturity of the extrusion mechanisms located in the plasma membrane together with hyperactivity of the SERCA pump in the SR.
The termination of local Ca 2ϩ signaling and the maintenance of basal Ca 2ϩ levels require active transport either to the external medium, via PMCA and NCX, or into subcellular stores through the SERCA pump (36) . The relative importance of these systems depends on both the type and status of the cell (7), and we (13) have recently shown that these mechanisms are altered in aging. Our data suggest that in the newborn, both PMCA and NCX are not of importance in the recovery of basal Ca 2ϩ levels since the inhibition of both mechanisms does not alter the speed of the recovery. This lack of function could also collaborate in the high Ca 2ϩ levels in response to CCK and caffeine, since these two important extrusion systems would not be operative in neonatal tissue. In contrast, in hippocampal neurons, all major Ca 2ϩ extrusion systems are strongly upregulated during the first 2 wk of postnatal development as a consequence of changes in the expression and cellular localization of different isoforms of Ca 2ϩ pumps and exchangers (18) . Human neonatal erythrocytes have fewer PMCA molecules, which also exhibit reduced PMCA activity compared with children erythrocytes, indicating that postnatal PMCA undergo developmental changes postnatally (22) .
The data reported herein indicate that in neonatal gallbladder smooth muscle, the recovery of resting Ca 2ϩ levels is achieved mainly by SERCA pump activation, since the SERCA inhibitor TPS had more robust effects in newborn cells than in adult cells. However, we did not find increased expression of the ATPase in the neonatal tissue, which may suggest that changes in the activity account for our findings. PLB is a 30-kDa pentameric protein associated with SERCA that functions as an inhibitor of SERCA via a mechanism involved in decreasing its affinity for Ca 2ϩ (23) . Importantly, phosphorylation of PLB relieves this inhibition and has long been known to be involved in the modulation of smooth muscle contractility (30) . In this study, we found decreased expression of PLB and, more importantly, an increase in PLB phosphorylation in response to CCK, which would result in deinhibited SERCA in the newborn. Based in these results, one might anticipate a higher Ca 2ϩ release upon stimulation due to increased Ca 2ϩ loading and a more rapid Ca 2ϩ removal upon washout, in agreement with findings in cardiac muscle (25) . Both effects were observed, which, together with the higher load of Ca 2ϩ stores demonstrated by ionomycin treatment, support our hypothesis that in the newborn smooth muscle, contractility relies mainly on Ca 2ϩ release-dependent mechanisms. Interestingly, although our results indicate that Ca 2ϩ extrusion is downregulated in neonate cells, these cells are able to decrease Ca 2ϩ levels upon CCK washout even during inhibition of SERCA by TPS. Our interpretation is that deinhibited SERCA would reduce the contribution of extrusion mechanisms to the decrease in Ca 2ϩ , which would have a more relevant role when SERCA is inhibited. It could also be possible that other intracellular organelles collaborate in restoring Ca 2ϩ resting levels after Fig. 7 . Expression of proteins involved in the PKCdependent Ca 2ϩ sensitization pathway is decreased in the newborn. A, left: original Western blots on gallbladder smooth muscle from adult and newborn animals. The histogram (right) shows summarized data of changes in protein expression in both experimental groups. For each protein, the band optic density is expressed with respect to that of actin to correct the amount of protein loaded. In the newborn, there was reduced expression of p-PKC, but the level of expression of the effector C-kinasedependent inhibitor of 17 kDa (CPI-17) was similar in both age groups. B, left: representative Western blots using anti-p-Thr 38 -CPI-17 and anti-CPI-17 in unstimulated (control) or CCK-treated adult and newborn samples. The histogram (right) shows summarized data of changes in CCK-induced CPI-17 phosphorylation in 6 experiments. After referenced to actin content, optic density of p-CPI-17 (top) versus total CPI-17 (bottom) was calculated for control and CCK-treated samples in both age groups, and the ratio for CCK-treated samples was expressed as the fold increase with respect to unstimulated conditions. Note that CCK-induced CPI-17 phosphorylation was decreased in the newborn. *P Ͻ 0.05 and **P Ͻ 0.01 by ANOVA.
agonist stimulation since in the presence of inhibitors of Ca 2ϩ extrusion mechanisms and the SERCA pump, CCK induced a transient response, although there was a delay in Ca 2ϩ decay, especially in adult cells. We cannot rule out that the inhibitors partially blocked their targets.
What it is clear in our study is that changes in Ca 2ϩ homeostasis cannot explain the reduced gallbladder contractility in the newborn. Instead, evidence for development-related alterations in Ca 2ϩ sensitization mechanisms is presented. First, stimulation with CCK induced a higher increase in [Ca 2ϩ ] i in neonatal tissues than in adult tissues, whereas it yielded a reduced contractile response in newborn muscle. Second, specific inhibitors of the Ca 2ϩ sensitization pathways inhibited the contractile response induced by CCK in adult gallbladder smooth muscle but had less effect in newborn strips. The selectivity of Y-27632 in the inhibition of ROCK activity and consequently decreasing the tone of gastrointestinal smooth muscle has been recently shown (34) . Third, the expression of protein components of RhoA/ROCK and PKC/ CPI-17 pathways was diminished in the newborn. Fourth, the final effectors MYPT1 and CPI-17 were not activated in response to stimuli in the newborn. It has been shown that Ca 2ϩ sensitization is a process developmentally regulated in smooth muscle. Thus, in detrusor smooth muscle, lower MLCP activity in newborn tissue provides a mechanism for increased Ca 2ϩ sensitivity (11) as a compensation for a less developed SR or not fully functional Ca 2ϩ influx pathways in newborn smooth muscle (42) . In the uterus, where the SR is a large and functionally important Ca 2ϩ store in the neonate, Ca 2ϩ sensitization plays a prominent role in neonatal smooth muscle, although the mechanisms for such Ca 2ϩ sensitization have not been explored (31) . Similarly, myofilament Ca 2ϩ sensitivity is upregulated in fetal compared with adult cerebral arteries, related to a lower abundance of MLCP (37) and RhoAdependent and PKC-independent mechanisms (2). Our results clearly indicate that upregulated Ca 2ϩ sensitization is not a general phenomenon in smooth muscle development. Although immediately after birth coordinated motor activity of the gut is not fully developed, intestinal transit occurs through myogenic motor patterns (35) . Later, development of organized neural networks, coupling between muscle and intersticial cells of Cajal, and smooth muscle maturation of both Ca 2ϩ -dependent and -independent mechanisms will make gut motility adult in pattern.
In summary, we documented significant development-related changes in the contractility of gallbladder smooth muscle, which can be explained by not fully developed Ca 2ϩ homeostasis and decreased Ca 2ϩ sensitization. Taken together, the present data emphasize that gastrointestinal smooth muscle contractility early at birth is not upregulated by Ca 2ϩ sensitization mechanisms and mainly relies on Ca 2ϩ release from a fully loaded SR, the result of unfunctional Ca 2ϩ extrusion mechanisms and PLB-mediated SERCA inhibition.
